|
IL73534A
(en)
*
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US4938949A
(en)
*
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5238944A
(en)
*
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
US5736553A
(en)
*
|
1988-12-15 |
1998-04-07 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
|
|
US5037986A
(en)
*
|
1989-03-23 |
1991-08-06 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US4929624A
(en)
*
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
NZ232740A
(en)
*
|
1989-04-20 |
1992-06-25 |
Riker Laboratories Inc |
Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
|
|
CA2093132C
(en)
*
|
1990-10-05 |
2002-02-26 |
John F. Gerster |
Process for the preparation of imidazo[4,5-c]quinolin-4-amines
|
|
US5175296A
(en)
*
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
|
IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US5395937A
(en)
*
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
US5648516A
(en)
*
|
1994-07-20 |
1997-07-15 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
US5352784A
(en)
*
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
US5525606A
(en)
*
|
1994-08-01 |
1996-06-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
|
|
DE19505168A1
(de)
*
|
1995-02-16 |
1996-08-22 |
Boehringer Mannheim Gmbh |
Spezifische Lipidkonjugate von Nucleosid-Diphosphonaten und deren Verwendung als Arzneimittel
|
|
US5624677A
(en)
*
|
1995-06-13 |
1997-04-29 |
Pentech Pharmaceuticals, Inc. |
Controlled release of drugs delivered by sublingual or buccal administration
|
|
US5741908A
(en)
*
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
|
US5693811A
(en)
*
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
|
DE19637209B4
(de)
*
|
1996-09-12 |
2006-12-14 |
Siemens Ag |
Verfahren zum Steuern des Antriebsstrangs eines Kraftfahrzeugs und integrierte Antriebsstrangsteuerung
|
|
HUP9904665A3
(en)
*
|
1996-10-25 |
2000-11-28 |
Minnesota Mining And Mfg Co Sa |
Immune response modifier compounds for treatment of th2 mediated and related diseases
|
|
CA2309350C
(en)
*
|
1997-11-12 |
2007-04-03 |
Mitsubishi Chemical Corporation |
Purine derivatives and medicaments comprising the same as active ingredient
|
|
CA2311742C
(en)
*
|
1997-11-28 |
2009-06-16 |
Sumitomo Pharmaceuticals Co., Ltd. |
6-amino-9-benzyl-8-hydroxypurine derivatives
|
|
US7001609B1
(en)
*
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
|
US6486168B1
(en)
*
|
1999-01-08 |
2002-11-26 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
|
US20020058674A1
(en)
*
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
|
NZ512628A
(en)
*
|
1999-01-08 |
2004-03-26 |
3M Innovative Properties Co |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
|
CZ27399A3
(cs)
*
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
DE60118521T2
(de)
*
|
2000-01-07 |
2006-10-12 |
Universitaire Instelling Antwerpen |
Purin derivate, ihre herstellung und verwendung
|
|
US6533645B2
(en)
*
|
2000-01-18 |
2003-03-18 |
Applied Materials, Inc. |
Substrate polishing article
|
|
US6733764B2
(en)
*
|
2000-06-14 |
2004-05-11 |
Alain Martin |
Immunostimulator anti-cancer compounds and methods for their use in the treatment of cancer
|
|
JP2004510961A
(ja)
*
|
2000-09-15 |
2004-04-08 |
ビルコ・ビーブイビーエイ |
疾患の処置のための薬物療法を最適化するシステムおよび方法
|
|
WO2002030399A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Johns Hopkins University |
Polymer controlled delivery of a therapeutic agent
|
|
US20020127224A1
(en)
*
|
2001-03-02 |
2002-09-12 |
James Chen |
Use of photoluminescent nanoparticles for photodynamic therapy
|
|
EP1767525A1
(en)
*
|
2001-04-09 |
2007-03-28 |
Novartis Vaccines and Diagnostics, Inc. |
Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists
|
|
JP4331944B2
(ja)
*
|
2001-04-17 |
2009-09-16 |
大日本住友製薬株式会社 |
新規アデニン誘導体
|
|
JP4335000B2
(ja)
*
|
2001-06-29 |
2009-09-30 |
シーブイ・セラピューティクス・インコーポレイテッド |
Ａ２ｂアデノシン・レセプタ拮抗剤
|
|
EP1440072A4
(en)
*
|
2001-10-30 |
2005-02-02 |
Conforma Therapeutic Corp |
PURINE ANALOGS HAVING HSP90 INHIBITORY ACTIVITY
|
|
KR101111085B1
(ko)
*
|
2002-09-27 |
2012-04-12 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
신규 아데닌 화합물 및 그 용도
|
|
US20040202663A1
(en)
*
|
2003-01-28 |
2004-10-14 |
Shanghai Sunway Biotech Co., Ltd. |
Therapy for primary and metastatic cancers
|
|
US20040265351A1
(en)
*
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
|
WO2005016235A2
(en)
*
|
2003-04-14 |
2005-02-24 |
The Regents Of The University Of California |
Combined use of impdh inhibitors with toll-like receptor agonists
|
|
US20050059613A1
(en)
*
|
2003-07-08 |
2005-03-17 |
Bahram Memarzadeh |
Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
|
|
WO2005020892A2
(en)
*
|
2003-08-08 |
2005-03-10 |
Mitochroma Research, Inc. |
Pharmaceutical compositions and methods for metabolic modulation
|
|
ATE465742T1
(de)
*
|
2003-09-05 |
2010-05-15 |
Anadys Pharmaceuticals Inc |
Tlr7-liganden zur behandlung von hepatitis c
|
|
NZ546611A
(en)
*
|
2003-09-18 |
2010-02-26 |
Conforma Therapeutics Corp |
Novel heterocyclic compounds as HSP90-inhibitors
|
|
FR2863890B1
(fr)
*
|
2003-12-19 |
2006-03-24 |
Aventis Pasteur |
Composition immunostimulante
|
|
AU2005219413A1
(en)
*
|
2004-03-02 |
2005-09-15 |
Massachusetts Institute Of Technology |
Nanocell drug delivery system
|
|
US8012964B2
(en)
*
|
2004-03-26 |
2011-09-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
9-substituted 8-oxoadenine compound
|
|
CA2587676A1
(en)
*
|
2004-11-19 |
2006-05-26 |
Institut Gustave Roussy |
Improved treatment of cancer by double-stranded rna
|
|
WO2006065234A1
(en)
*
|
2004-12-10 |
2006-06-22 |
University Of Pittsburgh |
Use of lipid and hydrogel vehicles for treatment and drug delivery
|
|
US20070292418A1
(en)
*
|
2005-04-26 |
2007-12-20 |
Eisai Co., Ltd. |
Compositions and methods for immunotherapy
|
|
JP2009504803A
(ja)
*
|
2005-08-22 |
2009-02-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Ｔｌｒアゴニスト
|
|
US20090118263A1
(en)
*
|
2005-09-22 |
2009-05-07 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel Adenine Compound
|
|
US20090105212A1
(en)
*
|
2005-09-22 |
2009-04-23 |
Dainippon Sumitomo Pharma Co., Ltd. a corporation of Japan |
Novel adenine compound
|
|
US20070100146A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Trevor Dzwiniel |
Process for the preparation of imidazo[4,5-c]-quinolin-4-amines
|
|
EP2029597A4
(en)
*
|
2006-05-31 |
2011-11-23 |
Univ California |
purine analogs
|
|
PT2038290E
(pt)
*
|
2006-07-07 |
2013-12-10 |
Gilead Sciences Inc |
Moduladores de receptor do tipo toll 7
|
|
US7902187B2
(en)
*
|
2006-10-04 |
2011-03-08 |
Wyeth Llc |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
|
CL2007002866A1
(es)
*
|
2006-10-04 |
2008-07-04 |
Pharmacopeia Inc |
Compuestos derivados de 6-sustituidos-2-(bencimidazolil) purina y purinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades autoinmunes, enfermedad inflamatoria, enfermedad mediada por m
|
|
ES2456964T3
(es)
*
|
2007-02-07 |
2014-04-24 |
The Regents Of The University Of California |
Conjugados de agonistas de TLR sintéticos y usos de los mismos
|
|
SI2170888T1
(sl)
*
|
2007-06-29 |
2015-10-30 |
Gilead Sciences, Inc. |
Purinski derivati in njihova uporaba kot modulatorjev receptorja tipa toll-7
|
|
WO2009052310A1
(en)
*
|
2007-10-16 |
2009-04-23 |
Cv Therapeutics, Inc |
A3 adenosine receptor antagonists
|
|
WO2010093436A2
(en)
*
|
2009-02-11 |
2010-08-19 |
Carson Dennis A |
Toll-like receptor modulators and treatment of diseases
|
|
MX2012004706A
(es)
*
|
2009-10-22 |
2012-06-08 |
Gilead Sciences Inc |
Derivados de purina o deazapurina utiles para el tratamiento de (inter alia) infecciones virales.
|
|
WO2011134668A1
(en)
*
|
2010-04-30 |
2011-11-03 |
Telormedix Sa |
Phospholipid drug analogs
|
|
EP2563401A1
(en)
*
|
2010-04-30 |
2013-03-06 |
Telormedix SA |
Methods for inducing an immune response
|
|
MX343914B
(es)
*
|
2010-09-01 |
2016-11-18 |
Glaxosmithkline Biologicals Sa |
Adsorcion de inmunopotenciadores en sales metalicas insolubles.
|
|
WO2012038058A1
(en)
*
|
2010-09-21 |
2012-03-29 |
Telormedix Sa |
Treatment of conditions by toll-like receptor modulators
|